|
|
Adelaide Chambers, Peter Street
Dublin, Ireland
phone:(353) (0) 1449 3250
fax:(353) (0) 1449 3251
|
|
| Symbol |
AGI |
| Exchange |
SEA |
| Founded |
0 |
| Employees |
|
|
|
| www.agitherapeutics.com/
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutic products for gastroenterological diseases and disorders. |
|
| Management |
| John Devane Ph.D, Chief Executive Officer; Mary Martin Ph.D, Chief Operating Officer; David Young, Ph.D, President, US Operations; David Kelly, Chief Financial Officer; Patrick Ashe, Senior Vice President, Business Development; John Kelly PhD, Chief Scientific Adviser |
| |
|
|
|
|
|
|
|
| Keywords |
| gastroenterological, irritable bowel syndrome, non-ulcer dyspepsia , functional diarrhoea and gastroparesis, acid disorders, such as gastroesophageal, reflux, esophagus, inflammatory, diseases, ulcerative, colitis, crohns |
|
|
|
| Description |
|
AGI Therapeutics is engaged in the development of innovative therapeutic products to treat a variety of gastroenterological diseases and disorders. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
